Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated:  10/30/2015
Statesboro OB/GYN Specialists
2353
mi
from 98109
Statesboro, GA
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated: 10/30/2015
Statesboro OB/GYN Specialists
2353
mi
from 98109
Statesboro, GA
Click here to add this to my saved trials
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated:  10/30/2015
Shaw Center for Women's Health
2325
mi
from 98109
Thomasville, GA
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated: 10/30/2015
Shaw Center for Women's Health
2325
mi
from 98109
Thomasville, GA
Click here to add this to my saved trials
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated:  10/30/2015
Athens OBGYN
2216
mi
from 98109
Athens, GA
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated: 10/30/2015
Athens OBGYN
2216
mi
from 98109
Athens, GA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2038
mi
from 98109
Huntsville, AL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2038
mi
from 98109
Huntsville, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
979
mi
from 98109
Anaheim, CA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
979
mi
from 98109
Anaheim, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2730
mi
from 98109
Coral Gables, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2730
mi
from 98109
Coral Gables, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2719
mi
from 98109
Hollywood, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2719
mi
from 98109
Hollywood, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2603
mi
from 98109
Melbourne, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2603
mi
from 98109
Melbourne, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2730
mi
from 98109
South Miami, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2730
mi
from 98109
South Miami, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2692
mi
from 98109
West Palm Beach, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2692
mi
from 98109
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1678
mi
from 98109
Peoria, IL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1678
mi
from 98109
Peoria, IL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1807
mi
from 98109
Mishawaka, IN
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1807
mi
from 98109
Mishawaka, IN
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1370
mi
from 98109
Council Bluffs, IA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1370
mi
from 98109
Council Bluffs, IA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1420
mi
from 98109
Newton, KA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1420
mi
from 98109
Newton, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2312
mi
from 98109
Rockville, MD
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2312
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1393
mi
from 98109
Edina, MN
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1393
mi
from 98109
Edina, MN
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1372
mi
from 98109
Bellevue, NE
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1372
mi
from 98109
Bellevue, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1366
mi
from 98109
Omaha, NE
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2264
mi
from 98109
Endwell, NY
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2264
mi
from 98109
Endwell, NY
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2355
mi
from 98109
Cary, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2355
mi
from 98109
Cary, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2358
mi
from 98109
Raleigh, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2358
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2455
mi
from 98109
Wilmington, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2455
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2487
mi
from 98109
Warwick, RI
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2487
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2227
mi
from 98109
Anderson, SC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2227
mi
from 98109
Anderson, SC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2424
mi
from 98109
Mt. Pleasant, SC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2424
mi
from 98109
Mt. Pleasant, SC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1304
mi
from 98109
Dakota Dunes, SD
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1304
mi
from 98109
Dakota Dunes, SD
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1775
mi
from 98109
Austin, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1775
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1775
mi
from 98109
Austin, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1775
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1660
mi
from 98109
Fort Worth, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1660
mi
from 98109
Fort Worth, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1604
mi
from 98109
San Angelo, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1604
mi
from 98109
San Angelo, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
710
mi
from 98109
South Jordan, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
710
mi
from 98109
South Jordan, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2038
mi
from 98109
Huntsville, AL
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2038
mi
from 98109
Huntsville, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2151
mi
from 98109
Mobile, AL
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2151
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1128
mi
from 98109
Chandler, AZ
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1128
mi
from 98109
Chandler, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1124
mi
from 98109
Mesa, AZ
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1124
mi
from 98109
Mesa, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1124
mi
from 98109
Mesa, AZ
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1124
mi
from 98109
Mesa, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1817
mi
from 98109
Harrisburg, AR
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1817
mi
from 98109
Harrisburg, AR
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1806
mi
from 98109
Jonesboro, AR
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1806
mi
from 98109
Jonesboro, AR
Click here to add this to my saved trials